Compounds, complexes, and methods useful for detecting and/or treating bacterial pathogens

1. A compound of formula I, II or III:

wherein:

each X independently represents H and the vicinal Y represents H or -L-B; or each Y independently represents H and the vicinal X represents H or -L-B;

each Z independently represents H or -L-B;

each L independently represents an organic linking group;

each B independently represents —OR, —NR 2 , —SR, —C(O)OR, —C(O)NR 2 , —S(O)R, or —SO 2 R;

each R independently represents H or an organic group;

each b is independently 0 or 1;

each c is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one of X, Y, or Z is present and represents -L-B; and

wherein at least one R is an organic group, said organic group comprising a group selected from the group consisting of a dye, a Lanthanide complex, a magnetic resonance imaging (MM) contrast agent, a positron emission tomography (PET) agent, a gold nanoparticle, a silver nanoparticle, a quantum dot, an antibiotic or an antibacterial drug, an antimicrobial peptide, a polymer, a dendrimer, an ionophore, and combinations thereof.

2. The compound of claim 1 , wherein each organic linking group L independently represents a straight-chain group of the formula —(CH 2 ) n — or —(CH 2 —CH 2 —O) n —, wherein n is 1 to 8.

3. The compound of claim 1 , wherein each organic linking group L independently represents a branched chain dendrimer that contains one or more of C, N, S, and O.

4. A compound of formula II,

wherein:

each Q independently represents H or —(CH 2 ) n -D, wherein n is 1 to 8;

each D independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group; and

each d is independently 2 to 5;

with the proviso that at least one Q represents —(CH 2 ) n -D; and

wherein at least one R is an organic group, said organic group comprising a group selected from the group consisting of a dye, a Lanthanide complex, a magnetic resonance imaging (MRI) contrast agent, a positron emission tomography (PET) agent, a gold nanoparticle, a silver nanoparticle, a quantum dot, an antibiotic or an antibacterial drug, an antimicrobial peptide, a polymer, a dendrimer, and ionophore, and combinations thereof.

5. A compound of formula III:

wherein:

each A independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group;

each n is independently 2 to 5;

each e is independently 0 or 1;

each f is independently 2 or 3;

each g is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one A is present and

wherein at least one R is an organic group comprising a group selected from the group consisting of a dye, a Lanthanide complex, a magnetic resonance imaging (MM) contrast agent, a positron emission tomography (PET) agent, a gold nanoparticle, a silver nanoparticle, a quantum dot, an antibiotic or an antibacterial drug, an antimicrobial peptide, a polymer, a dendrimer, an ionophore, and combinations thereof.

6. A complex of a compound of claim 1 selected from the group consisting of a Ga(III) complex, an Fe(III) complex, an Al(III) complex, a V(IV) complex, a Zn(II) complex, an Y(III) complex, a Zr(VI) complex, a Cu(II) complex, and combinations thereof.

7. A complex of a compound of claim 4 selected from the group consisting of a Ga(III) complex, an Fe(III) complex, an Al(III) complex, a V(IV) complex, a Zn(II) complex, an Y(III) complex, a Zr(VI) complex, a Cu(II) complex, and combinations thereof.

8. A complex of a compound of claim 5 selected from the group consisting of a Ga(III) complex, an Fe(III) complex, an Al(III) complex, a V(IV) complex, a Zn(II) complex, an Y(III) complex, a Zr(VI) complex, a Cu(II) complex, and combinations thereof.

9. A method of detecting bacteria comprising:

contacting a probe comprising a compound of formula I, II or III:

wherein:

each X independently represents H and the vicinal Y represents H or -L-B; or each Y independently represents H and the vicinal X represents H or -L-B;

each Z independently represents H or -L-B;

each L independently represents an organic linking group;

each B independently represents —OR, —NR 2 , —SR, —C(O)OR, —C(O)NR 2 , —S(O)R, or —SO 2 R;

each R independently represents H or an organic group;

each b is independently 0 or 1;

each c is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one of X, Y, or Z is present and represents -L-B;

wherein:

each Q independently represents H or —(CH 2 ) n -D, wherein n is 1 to 8;

each D independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group; and

each d is independently 2 to 5;

with the proviso that at least one Q represents —(CH 2 ) n -D; or

wherein:

each A independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group;

each n is independently 2 to 5;

each e is independently 0 or 1;

each f is independently 2 or 3;

each g is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one A is present,

with a sample comprising a component selected from the group consisting of a bodily fluid, an isolated colony, a culture, and combinations thereof, under conditions effective for the probe to complex Fe(III), Al(III), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II) present in the bodily fluid, the isolated colony, and/or the culture; and

detecting the presence of Fe(III), Al(III), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II)-probe complex to indicate the presence of bacteria in the bodily fluid, the isolated colony, and/or the culture;

wherein for each of a compound of formula I, II or III, at least one R is an organic group, said organic group comprises a group selected from the group consisting of a dye, a Lanthanide complex, a magnetic resonance imaging (MRI) contrast agent, a positron emission tomography (PET) agent, a gold nanoparticle, a silver nanoparticle, a quantum dot, an antibiotic or an antibacterial drug, an antimicrobial peptide, a polymer, a dendrimer, an ionophore, and combinations thereof.

10. The method of claim 9 further comprising determining the concentration of the Fe(III), ARM), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II)-probe complex to indicate the concentration of bacteria in the bodily fluid, the isolated colony, and/or the culture, wherein the concentration of the Fe(III), ARM), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II)-probe complex is determined by a technique selected from the group consisting of fluorescence, positron emission tomography (PET), magnetic resonance imaging (MM), field microscopy, colorimetry, electrochemistry, mass spectrometry (MS), fluorescence spectroscopy, and combinations thereof.

11. The method of claim 9 , wherein conditions effective for the probes and/or metal-probe complexes to be recognized by bacteria comprise contacting the probe and the sample for 1 minute to 1 hour at 10° C. to 40° C.

12. A method of detecting bacteria comprising:

contacting a probe comprising a compound of formula I, II or III:

wherein:

each X independently represents H and the vicinal Y represents H or -L-B; or each Y independently represents H and the vicinal X represents H or -L-B;

each Z independently represents H or -L-B;

each L independently represents an organic linking group;

each B independently represents —OR, —NR 2 , —SR, —C(O)OR, —C(O)NR 2 , —S(O)R, or —SO 2 R;

each R independently represents H or an organic group;

each b is independently 0 or 1;

each c is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one of X, Y, or Z is present and represents -L-B;

wherein:

each Q independently represents H or —(CH 2 ) n -D, wherein n is 1 to 8;

each D independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group; and

each d is independently 2 to 5;

with the proviso that at least one Q represents —(CH 2 ) n -D; or

wherein:

each A independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group;

each n is independently 2 to 5;

each e is independently 0 or 1;

each f is independently 2 or 3;

each g is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one A is present,

wherein for each of a compound of formula I, II or III, at least one R is an organic group, said organic group comprising a group selected from the group consisting of a dye, a Lanthanide complex, a magnetic resonance imaging (MRI) contrast agent, a positron emission tomography (PET) agent, a gold nanoparticle, a silver nanoparticle, a quantum dot, an antibiotic or an antibacterial drug, an antimicrobial peptide, a polymer, a dendrimer, an ionophore, and combinations thereof;

with a sample comprising a bodily fluid, under conditions effective for the probe to complex Fe(III), Al(III), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II) present in the bodily fluid; and

detecting the presence of Fe(III), Al(III), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II)-probe complex to indicate the presence of bacteria in the bodily fluid,

wherein the sample comprising the bodily fluid is selected from the group consisting of urine, blood, cerebrospinal fluid (CSF), pleural fluid, a bacteria culture, an isolated colony reconstituted in media, and combinations thereof.

13. The method of claim 9 , wherein the detected bacteria is Gram-negative or Gram-positive.

14. A method of determining susceptibility of bacteria to an antibiotic comprising:

treating a sample comprising a component selected from the group consisting of a bodily fluid, a bacteria culture, a single colony reconstituted in media with an antibiotic, and combinations thereof;

contacting a probe comprising a compound of formula I, II or III:

wherein:

each X independently represents H and the vicinal Y represents H or -L-B; or each Y

independently represents H and the vicinal X represents H or -L-B;

each Z independently represents H or -L-B;

each L independently represents an organic linking group;

each B independently represents —OR, —NR 2 , —SR, —C(O)OR, —C(O)NR 2 , —S(O)R, or —SO 2 R;

each R independently represents H or an organic group;

each b is independently 0 or 1;

each c is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one of X, Y, or Z is present and represents -L-B;

wherein:

each Q independently represents H or —(CH 2 ) n -D, wherein n is 1 to 8;

each D independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group; and

each d is independently 2 to 5;

with the proviso that at least one Q represents —(CH 2 ) n -D; or

wherein:

each A independently represents —OR, —NR 2 , —SR, or —C(O)OR;

each R independently represents H or an organic group;

each n is independently 2 to 5;

each e is independently 0 or 1;

each f is independently 2 or 3;

each g is independently 0 or 1; and

x=0 to 3;

with the proviso that at least one A is present,

wherein for each of a compound of formula I, II or III, at least one R is an organic group, said organic group comprising a group selected from the group consisting of a dye, a Lanthanide complex, a magnetic resonance imaging (MRI) contrast agent, a positron emission tomography (PET) agent, a gold nanoparticle, a silver nanoparticle, a quantum dot, an antibiotic or an antibacterial drug, an antimicrobial peptide, a polymer, a dendrimer, an ionophore, and combinations thereof;

with the sample comprising the bodily fluid, the isolated colony, and/or the culture under conditions effective for the probe to complex Fe(III); and

determining the change in concentration of the compound or complex to indicate the concentration of bacteria in the bodily fluid, the bacteria culture, or the isolated colony after treatment with the antibiotic,

wherein the difference between the initial concentration of bacteria and the concentration of bacteria in the bodily fluid, the bacteria culture, or the isolated colony after treatment with the antibiotic is an indication of the susceptibility of the bacteria to the antibiotic.

15. The method of claim 14 , wherein the concentration of the Fe(III), Al(III), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II)-probe complex is determined by a technique selected from the group consisting of fluorescence, positron emission tomography (PET), magnetic resonance imaging (MRI), field microscopy, colorimetry, electrochemistry, mass spectrometry (MS), fluorescence spectroscopy, and combinations thereof.

16. A compound selected from the group consisting of:

17. The method of claim 9 , wherein the presence of the Fe(III), V(IV), Zn(II), Y(III), Zr(IV), and/or Cu(II)-probe complex is detected by a technique selected from the group consisting of fluorescence, positron emission tomography (PET), magnetic resonance imaging (MRI), field microscopy, colorimetry, electrochemistry, mass spectrometry (MS), fluorescence spectroscopy, and combinations thereof.